Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Gefitinib [cytosol]

Class:Id	ChemicalDrug:1169429
_displayName	Gefitinib [cytosol]
_timestamp	2018-12-12 00:29:42
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:1169430] Orlic-Milacic, Marija, 2011-01-18
crossReference	[DatabaseIdentifier:9628106] ChEBI:49668
disease	[Disease:1500689] cancer
literatureReference	[LiteratureReference:1181162] ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy [LiteratureReference:1169414] Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity
modified	[InstanceEdit:1169436] Orlic-Milacic, Marija, 2011-01-18 [InstanceEdit:1181158] Orlic-Milacic, Marija, 2011-01-28 [InstanceEdit:1181170] Orlic-Milacic, Marija, 2011-01-28 [InstanceEdit:1217487] Orlic-Milacic, Marija, 2011-02-16 [InstanceEdit:1220594] Orlic-Milacic, Marija, 2011-02-22 [InstanceEdit:1667319] Orlic-Milacic, Marija, 2011-10-14 [InstanceEdit:9016686] Orlic-Milacic, Marija, 2017-08-14 [InstanceEdit:9028147] Weiser, JD [InstanceEdit:9616752] Shorser, Solomon, 2018-08-13 [InstanceEdit:9619953] Wu, G, 2018-09-19 [InstanceEdit:9627975] Wu, G, 2018-11-05 [InstanceEdit:9631716] Wu, G, 2018-12-12
name	Gefitinib Iressa ZD1839 Reversible tyrosine kinase inhibitor gefitinib EGFR specific
referenceEntity	[ReferenceTherapeutic:9016663] gefitinib [Guide to Pharmacology:4941]
stableIdentifier	[StableIdentifier:2018474] R-ALL-1169429.2
summation	[Summation:1181169] Gefitinib (ZD1839, Iressa) is a low-molecular-weight EGFR ty...
(hasComponent)	[Complex:1169431] EGFR G719S mutant:gefitinib [plasma membrane] [Homo sapiens] [Complex:9665139] ERBB2 L755_T759del:gefitinib [plasma membrane] [Homo sapiens]
(hasMember)	[DefinedSet:1176053] Reversible EGFR-specific TKIs [cytosol] [DefinedSet:9663690] neratinib,gefitinib [cytosol] [Homo sapiens] [DefinedSet:9665127] TKIs (ERBB2) [cytosol]
[Change default viewing format]

No pathways have been reviewed or authored by Gefitinib [cytosol] (1169429)